Control and Prevention of HIV/AIDS, STDs & STIs

A practicing physician in the field of healthcare in the state of Kerala in India for the last 30 years and very much interested in basic research. My interest is spread across the fever, inflammation and back pain. I am a writer. I already printed and published nine books on these subjects. I wrote hundreds of articles in various magazines. After scientific studies, we have developed 8000 affirmative cross checking questions. It can explain all queries related to fever.

Infectious Diseases

Anouar Alami studied Chemistry at Montpellier II University, France and He received his PhD in 1991. He then joined in 1992 the department of chemistry at the Faculty of Sciences Dhar El Marhaz, Sidi Mohamed Ben Abdellah University (Fez, Morocco). He obtained his state doctorate thesis degree in Organic Chemistry in 1997 at SMBAU. In parallel to all his responsibilities (Head of Department of Chemistry, Responsible for the doctoral training "Bioactive Molecules, Health and Biotechnologies", Director of the Laboratory of organic chemistry, Coordinator of the Bachelor's degree program "Chemistry Sciences"), he had prepared a DEUG (2008) and a License (2010) in Private Law in French and a Master in Economics and Management (2013) at the Faculty of Economics, Law, and Social Sciences of Fez. Concerning the scientific research side, He had published more than 85 research articles indexed in several databases (Scopus, Web of science, Elsevier, Eric, IMIST…).

Dr.Diane Williamson is a Dstl Fellow in Immunology, based at Porton Down. She has worked in R&D (starting in veterinary vaccinology and moving to human vaccines and therapies for serious pathogens) for 30 years. She has published extensively, on the theme of prophylaxis and therapy of serious human diseases for biodefence and emerging pathogens and has worked in the R& D pipeline from discovery to translation to the clinic. Additionally she is currently a Fellow of the Royal Society of Biology and of the Royal College of Pathology and has served as a Trustee and national Education secretary of the British Society for Immunology.

Ali Karami is currently working as a professor of Molecular Biology (Medical Biotechnology), Genetic Engineering and Bioinformatic Research Center of Molecular Biology, Baqyiatallah University of Medical Sciences. Tehran-IRAN. He is working and teaching in areas like Molecular Biotechnology, Rapid Molecular Detection of Infectious Diseases, like PCR, RT PCR, Microarray, Rapid Immunological detection methods, Point of care for detections, Surveillance and molecular Epidemiology of infectious diseases, Novel Vaccines like Recombinant and DNA vaccine and production of Recombinant Protein for Prevention, Detection and Treatment. Other areas that he has been working since last 25 years are Bioinformatics, Genomics, proteomics and System Biology, Biosafety, Biosecurity, Medical Bio-defence, Bioethics and BWC convention.

Dr Usha Dane has the below mentioned to her credit MBBS from BJ Medical College Pune India , FRHS (Fellow of Rural Health Service) MD Naturopathy Medicine. PGPD (Post Graduate Program in Diabetes) From John Hopkins School of Medicine Baltimore. She is Authorized Medical Attendant for Central Government Employees Government of India Panel Doctor for Employees State Insurance Scheme Government of Maharashtra India. Panel Doctor for Life Insurance Corporation of India.

Diabetes & Metabolism

Dr. Mayank Singhal is a graduate from University College of Medical Sciences and currently working as an Academic Hospitalist at Cape Fear Valley Hospital, NC, USA and affiliated with Methodist University as Associate Professor of Clinical Medicine. He is also teaching faculty for Internal Medicine Residency at Campbell University School of Osteopathic Medicine, USA. He is Board Certified in American Board of Internal Medicine (ABIM). He is a member of Society of Hospital Medicine and American College of Physicians. He is also active as a Reviewer for scholarly articles and member of Editorial board for journals.

Diabetes, Obesity and Metabolic Disorders.

Dr. Robert W. Buckingham joined PHHS after having previously been appointed as the Jack W. Thompson, M.D. Distinguished Visiting Professor at the University of Michigan-Flint in 2013-14. A Yale graduate, Dr. Buckingham was appointed inaugural Executive Director/Dean of the School of Public Health with the University of Saskatchewan, in 2009. He has authored more than 12 books and many scientific referred papers, with the most recent being a textbook entitled, “A Primer on International Health” published by Allyn & Bacon, and five books on hospice care, including, “Care of the Dying Child” published by the Continuum Publishing Company, which was translated in seven languages.

Dr. Buckingham, helped pioneer the development of the first Hospice in the U.S. and is considered one of the “Founding Fathers” of hospice in North America. He was the first Director of Research of hospice in Connecticut in 1974, and subsequently founded another 81 hospice programs worldwide, including a hospice for children afflicted with HIV/AIDS in Thailand. Dr. Buckingham has developed new collaborative research and scholarly exchanged programs with Mahidol University in Thailand, Hawassa University in Ethiopia, as well as the Nelson Mandela Institute of Science and Technology in Arusha, Tanzania and locally, with the Heart and Stroke Foundation of Saskatchewan.

evin Galalae is the world’s foremost independent authority on the globalization-depopulation axis around which the international system has revolved since the inception of the United Nations in 1945, and the first to expose and scientifically demonstrate the existence, methods and consequences of the Global Depopulation Policy. He is the founder and Director of the Center of Global Consciousness (CGC), which is dedicated to the eradication of all covert chemical, biological, psychosocial and economic methods of population control and to their replacement with overt population control legislation through a global replacement level fertility law.

Biological and bacteriological methods, Causes and Consequences of the Global Depopulation Policy and Chemical and Biological Depopulation.

Head of UNESCO Chair sexual health & Human rights, and Public health professor in Paris Diderot University

Sexual health, Human Rights, HIV, STIs, Brief Sexual Communication, globale approach in sexual education, training of sexuality educator

Giulio Tarro graduated from Medicine School, Naples University (1962). Research Associate, Division of Virology and Cancer Research, Children’s Hospital (1965-1968), Assistant Professor of Research Pediatrics, College Medicine (1968-1969), Cincinnati University, Ohio. Oncological Virology Professor, Naples University (1972-1985). Chief Division Virology (1973-2003), Head Department Diagnostic Laboratories, (2003-2006). D. Cotugno Hospital for Infectious Diseases, Naples; Emeritus, 2006 -. Since 2007 Chairman Committee of Biotechnologies and VirusSphere, World Academy Biomedical Technologies, UNESCO, Adjunct Professor Department Biology, Temple University, College of Science and Technology, Philadelphia, recipient of the Sbarro Health Research Organization lifetime achievement award (2010). President Foundation de Beaumont Bonelli for Cancer Research.

Infectious Diseases

Ishwar Gilada: A medical doctor, specialized in Skin & STDs with special training in HIV management, Managing Director and Consultant in HIV/AIDS at Unison Medicare& Research Centre-India’s first private sector comprehensive HIV Care clinic; President of AIDS Society of India (a professional organization of physicians in HIV care); Secretary General of Peoples Health Org. (India). He was Secretary General of ASI from 2005-2011 and the Jt. Sec. of National AIDS Committee, Govt of India (1995-97). He was the first to raise alarm against AIDS in 1985, is known for bringing India on AIDS control map, had started India’s first AIDS Clinic-1986 and has expertise in HIV care in resource-poor settings. He had trained several doctors, nurses and social workers; he was Editor-Publisher of AIDS ASIA from 1993 to 2008. He initiated, managed, supervised, evaluated over 40 HIV/AIDS projects in India, addressed over 3700 public meetings and training programs in India and abroad, has 235 scientific papers at conferences, written chapters in books on AIDS/STDs. He was consultant for American Foundation for AIDS Research (AmFAR), World Vision, USAID; has more than 65 awards to his credit including the "Outstanding Young Person of the World" –Glasgow in 1995 and Annemarie Madison Award-Germany in 1999 in Munich, Germany where he was termed as ‘the Indian Machinegun against AIDS’.

Specialized in Skin & STDs with special training in HIV management

Dr. Guirakhoo joined GeoVax as Senior Vice President R&D in October 2015. Dr. Guirakhoo was named one of the ‘50 Most Influential People in Vaccines’ in Vaccine Nation’s 2014 list. His previous assignment was Chief Technology Officer at Vaxess Technologies, a Cambridge, MA, based biotechnology company researching thermostabilization of vaccines and biologics using silk fibroin protein. Prior to this, he served as Chief Scientific Officer at Hookipa Biotech in Vienna, Austria, developing vaccines against Cytomegalovirus and cancers based on a novel replication deficient viral vector platform. Prior to that, Dr. Guirakhoo held the position of Executive Director of External R&D at Sanofi Pasteur from 2007-20012. Before joining Sanofi Pasteur in 2007, Dr. Guirakhoo was Head of Virology Research at Acambis for 15 years. During this time, he co-invented the ChimeriVax TM -technology platform in association with St. Louis University. This platform utilizes the YF 17D vaccine virus as a vector to develop chimeric live viruses. The ChimeriVaxTM vector platform was successfully used in the development of innovative vaccines such as: a) a single dose vaccine against Japanese encephalitis (IMOJEV™), marketed in Asian countries by Sanofi, b) a single dose veterinary vaccine for the prevention of West Nile encephalitis (PREVNILE™), marketed by Merck Animal Health, and c) DENGVAXIA®, the world’s first dengue vaccine approved in Mexico and Brazil in December 2015 and marketed by Sanofi. This tetravalent vaccine represents a historic milestone for half of the world population who lives at risk of dengue. Dr. Guirakhoo has over 30 years of experience in developing vaccines against infectious diseases. Dr. Guirakhoo holds a BSc in Biology, a MSc in genetics, and a PhD in Virology from the Medical University of Vienna, Austria, and was awarded a National Research Council post-doctoral fellowship at the National Center for Disease Control and Prevention in Fort Collins, CO, from 1990-1992.

Catherine Mullié obtained a PhD in Microbiology and a PharmD at the University of Lille, France, in 1999. After a post-doc year at the Faculté de Medicine in Amiens (Laboratoire d’Immunologie, INSERM-EMI 0351), she was appointed as assistant professor at the Faculté de Pharmacie in Amiens in 2000 and joined the LG-2A (Laboratoire de Glycochimie des Antimicrobiens et des Agroressources, UMR 7378 CNRS) in 2008. She has been a member of the French Society for Microbiology since 2000. Her research is focused on the development of new antimicrobial and antimalarial drugs, with a special interest in efflux-mediated antibiotic resistance in Pseudomonas aeruginosa and Acinetobacter baumannii. She currently heads the French part of a bilateral project funded by France and Algeria (Partenariat Hubert Curien Tassili) on this topic.

development of new antimicrobial and antimalarial drugs, with a special interest in efflux-mediated antibiotic resistance in Pseudomonas aeruginosa and Acinetobacter baumannii

Professor Dr. Andy I.M. Hoepelman (26-03-1955) is Head of the Department of Infectious Diseases in the University Medical Center Utrecht in the Netherlands. Until 2016 he was also the head of the Department of Internal medicine. Since August 1st 1998, he is Professor in Medicine. Dr. Hoepelman received his medical training from the University of Utrecht, receiving his Doctorate in 1978 and his MD degree in 1980. He completed two internships at the University in 1980 and 1985 to earn his board certification as a specialist in Internal Medicine. He received his PhD in 1989. In 1991/1992 he worked at the Rockefeller University, New York (Laboratory Prof. E. Tuomanen) and at the Memorial-Sloan Kettering (Department of Infectious Diseases, Prof.dr. D. Armstrong). In 1993, he was board certified as a specialist in Infectious Diseases. He also heads the training programme in Infectious Disease for internal medicine specialists at the University Hospital Utrecht. He is author/co-author of more than 400 published articles and is a member of several professional associations. His research interests are pathogenesis and treatment of HIV and viral hepatitis. He won a bronze medal in waterpolo at the Montreal Olympics

pathogenesis, treatment of HIV and viral hepatitis

Professor Janak Kishore is Chief of Serology and Molecular Virology in the department of Microbiology, Sanjay Gandhi Post-graduate Institute of Medical Sciences, India. He was Associate Editor Indian Journal of Virology, member National Academy Medical Sciences, American societies and Fellow of JICA, Japan. His passion is on healing and minimising human sufferings; on unveiling emerging viral infections and finding aetiologies in viral epidemics and in investigating undiagnosed/missed clinical infections so that appropriate treatment is given and life is saved. Dr. Kishore taught for over 30 yrs with pioneer work on parvovirus B19, developed in-house molecular techniques and published three novel clinical associations besides finding novel oncolytic property of B19. He also worked on cytomegalovirus, enteroviral haemorrhagic conjunctivitis, rubella. Dr Kishore published over 50 papers, served as reviewer for reputed journals, organized conferences, Chaired sessions and frequently invited to speak at international conferences.

Emerging viral infections,Viral epidemics and Clinical Infectious Diseases.

Dr Ashok Kapse is consulting Pediatrician practicing in the city of Surat in the Gujrat state of India, besides owning a private pediatric hospital he is also head of the pediatric department at a prestigious Mahavir super specialty hospital. He has special interest and skill in infectious diseases. Working along with CDC Atlanta he evolved simple clinical approach for diagnosis and management of Dengue illnesses particularly in resource limited situations. Recipient of many oration awards he is a popular and sought after speaker, he has delivered hundreds of lectures on Dengue, Malaria, Typhoid and antibiotic uses across the India. He has published more than 10 articles in reputed national & international journals also has contributed chapters in prestigious books.

Dengue, Malaria, Typhoid and Antibiotics